HI
PRTK

Harbour Investments’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Harbour Investments’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2
Closed -$4 – 3138
2023
Q2 		$4 Hold
2
– – ﹤0.01% 3020
2023
Q1 		$5 Hold
2
– – ﹤0.01% 2991
2022
Q4 		$4 Hold
2
– – ﹤0.01% 2992
2022
Q3 		$0 Hold
2
– – ﹤0.01% 2877
2022
Q2 		$0 Buy
+2
New +$4 ﹤0.01% 2877

Harbour Investments's PRTK Position: Q3 2023 in Review

Harbour Investments sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 2 shares — an estimated $4 sold.

Harbour Investments first reported a position in PRTK in Q2 2022 and held it in 5 quarters. The position peaked at $5 in Q1 2023. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

  • Harbour Investments reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Harbour Investments sold 2 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $4.
  • Harbour Investments first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2022 and held it in 5 quarters.
  • Harbour Investments's Paratek Pharmaceuticals, Inc. position peaked at $5 in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on Harbour Investments's 13F filing for Q3 2023, filed 15 Nov 2023.